Quarterly report [Sections 13 or 15(d)]

Net Loss per Common Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)

v3.25.2
Net Loss per Common Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Effect of dilutive securities:        
Total potentially dilutive securities (in shares) 28,494,561 31,147,090 28,494,561 31,147,090
Warrants to purchase shares of common stock        
Effect of dilutive securities:        
Total potentially dilutive securities (in shares) 14,166,644 14,166,644 14,166,644 14,166,644
Options to purchase shares of common stock        
Effect of dilutive securities:        
Total potentially dilutive securities (in shares) 3,509,029 6,585,611 3,509,029 6,585,611
Restricted shares of common stock        
Effect of dilutive securities:        
Total potentially dilutive securities (in shares) 10,818,888 10,394,835 10,818,888 10,394,835